Contributo scientifico, sviluppato generalmente su uno specifico argomento, che illustra risultati originali di una ricerca o presenta caratteristiche di review, cioè di discussione dello stato dell’arte o della letteratura entro un ambito scientifico definito. La rivista di pubblicazione deve presentare caratteristiche di scientificità. La tipologia non comprende editoriali, commenti brevi, repliche, abstract, errata, recensioni e prodotti similari, per i quali sono previste specifiche tipologie.
Risk factors for intubation in severe bronchiolitis: a useful tool to decide on an early intensive respiratory support
2023 Colombo, J; Gattoni, C; Carobbio, A; Nacoti, M; Pellicioli, I; Vedovati, S; Bonanomi, E
A reappraisal of the benefit-risk profile of hydroxyurea in polycythemia vera: A propensity-matched study
2017 Barbui, T; Vannucchi, Am; Finazzi, G; Finazzi, Mc; Masciulli, A; Carobbio, A; Ghirardi, A; Tognoni, G
Telomere shortening in Ph-negative chronic myeloproliferative neoplasms: a biological marker of polycythemia vera and myelofibrosis, regardless of hydroxycarbamide therapy
2013 Ruella, M; Salmoiraghi, S; Risso, A; Carobbio, A; Buttiglieri, S; Spatola, T; Sivera, P; Ricca, I; Barbui, T; Tarella, C; Rambaldi, A
Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome
2012 Barbui, T; Thiele, J; Passamonti, F; Rumi, E; Boveri, E; Randi, Ml; Bertozzi, I; Marino, F; Vannucchi, Am; Pieri, L; Rotunno, G; Gisslinger, H; Gisslinger, B; Mullauer, L; Finazzi, G; Carobbio, A; Gianatti, A; Ruggeri, M; Nichele, I; D'Amore, E; Rambaldi, A; Tefferi, A
Clinical outcomes under hydroxyurea treatment in polycythemia vera: a systematic review and meta-analysis
2019 Ferrari, A; Carobbio, A; Masciulli, A; Ghirardi, A; Finazzi, G; De Stefano, V; Vannucchi, Am; Barbui, T
Ruxolitinib for the prevention of thrombosis in polycythemia vera: a systematic review and meta-analysis
2020 Masciulli, A; Ferrari, A; Carobbio, A; Ghirardi, A; Barbui, T
Leukocytosis and risk stratification assessment in essential thrombocythemia
2008 Carobbio, A; Antonioli, E; Guglielmelli, P; Vannucchi, Am; Delaini, F; Guerini, V; Finazzi, G; Rambaldi, A; Barbui, T
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms
2018 De Stefano, V; Carobbio, A; Di Lazzaro, V; Guglielmelli, P; Iurlo, A; Finazzi, Mc; Rumi, E; Cervantes, F; Elli, Em; Randi, Ml; Griesshammer, M; Palandri, F; Bonifacio, M; Hernandez-Boluda, Jc; Cacciola, R; Miroslava, P; Carli, G; Beggiato, E; Ellis, Mh; Musolino, C; Gaidano, G; Rapezzi, D; Tieghi, A; Lunghi, F; Loscocco, Gg; Cattaneo, D; Cortelezzi, A; Betti, S; Rossi, E; Finazzi, G; Censori, B; Cazzola, M; Bellini, M; Arellano-Rodrigo, E; Bertozzi, I; Sadjadian, P; Vianelli, N; Scaffidi, L; Gomez, M; Cacciola, E; Vannucchi, Am; Barbui, T
A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms
2010 Rambaldi, A; Dellacasa, Cm; Finazzi, G; Carobbio, A; Ferrari, Ml; Guglielmelli, P; Gattoni, E; Salmoiraghi, S; Finazzi, Mc; Di Tollo, S; D'Urzo, C; Vannucchi, Am; Barosi, G; Barbui, T
Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia
2008 Carobbio, A; Finazzi, G; Antonioli, E; Guglielmelli, P; Vannucchi, Am; Delaini, F; Guerini, V; Ruggeri, M; Rodeghiero, F; Rambaldi, A; Barbui, T
The rate of transformation from JAK2-mutated ET to PV is influenced by an accurate WHO-defined clinico-morphological diagnosis
2015 Barbui, T; Thiele, J; Carobbio, A; Vannucchi, Am; Tefferi, A
Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)
2012 Barbui, T; Finazzi, G; Carobbio, A; Thiele, J; Passamonti, F; Rumi, E; Ruggeri, M; Rodeghiero, F; Randi, Ml; Bertozzi, I; Gisslinger, H; Buxhofer-Ausch, V; De Stefano, V; Betti, S; Rambaldi, A; Vannucchi, Am; Tefferi, A
Innovative haematological parameters for early diagnosis of sepsis in adult patients admitted in intensive care unit
2018 Buoro, S; Manenti, B; Seghezzi, M; Dominoni, P; Barbui, T; Ghirardi, A; Carobbio, A; Marchesi, G; Riva, I; Nasi, A; Ottomano, C; Lippi, G
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists
2016 De Stefano, V; Ruggeri, M; Cervantes, F; Alvarez-Larran, A; Iurlo, A; Randi, Ml; Elli, E; Finazzi, Mc; Finazzi, G; Zetterberg, E; Vianelli, N; Gaidano, G; Rossi, E; Betti, S; Nichele, I; Cattaneo, D; Palova, M; Ellis, Mh; Cacciola, R; Tieghi, A; Hernandez-Boluda, Jc; Pungolino, E; Specchia, G; Rapezzi, D; Forcina, A; Musolino, C; Carobbio, A; Griesshammer, M; Sant'Antonio, E; Vannucchi, Am; Barbui, T
Incidence of solid tumors in polycythemia vera treated with phlebotomy with or without hydroxyurea: ECLAP follow-up data
2018 Ghirardi, A; Carobbio, A; Masciulli, A; Barbui, T
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
2013 Tefferi, A; Rumi, E; Finazzi, G; Gisslinger, H; Vannucchi, Am; Rodeghiero, F; Randi, Ml; Vaidya, R; Cazzola, M; Rambaldi, A; Gisslinger, B; Pieri, L; Ruggeri, M; Bertozzi, I; Sulai, Nh; Casetti, I; Carobbio, A; Jeryczynski, G; Larson, Dr; Mullauer, L; Pardanani, A; Thiele, J; Passamonti, F; Barbui, T
The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600
2015 Massi, D; Brusa, D; Merelli, B; Falcone, C; Xue, G; Carobbio, A; Nassini, R; Baroni, G; Tamborini, E; Cattaneo, L; Audrito, V; Deaglio, S; Mandala, M
Splanchnic Vein Thromboses associated with Myeloproliferative Neoplasms: an international, retrospective study on 518 cases
2020 Sant'Antonio, E; Guglielmelli, P; Pieri, L; Primignani, M; Randi, Ml; Santarossa, C; Rumi, E; Cervantes, F; Delaini, F; Carobbio, A; Betti, S; Rossi, E; Lavi, N; Harrison, Cn; Curto-Garcia, N; Gisslinger, H; Gisslinger, B; Specchia, G; Ricco, A; Vianelli, N; Polverelli, N; Koren-Michowitz, M; Ruggeri, M; Girodon, F; Ellis, M; Iurlo, A; Mannelli, F; Mannelli, L; Sordi, B; Loscocco, Gg; Cazzola, M; De Stefano, V; Barbui, T; Tefferi, A; Vannucchi, Am
Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?
2009 Barbui, T; Carobbio, A; Rambaldi, A; Finazzi, G
Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3
2011 Barbui, T; Carobbio, A; Finazzi, G; Vannucchi, Am; Barosi, G; Antonioli, E; Guglielmelli, P; Pancrazzi, A; Salmoiraghi, S; Zilio, P; Ottomano, C; Marchioli, R; Cuccovillo, I; Bottazzi, B; Mantovani, A; Rambaldi, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Risk factors for intubation in severe bronchiolitis: a useful tool to decide on an early intensive respiratory support | 1-gen-2023 | Colombo, J; Gattoni, C; Carobbio, A; Nacoti, M; Pellicioli, I; Vedovati, S; Bonanomi, E | |
| A reappraisal of the benefit-risk profile of hydroxyurea in polycythemia vera: A propensity-matched study | 1-gen-2017 | Barbui, T; Vannucchi, Am; Finazzi, G; Finazzi, Mc; Masciulli, A; Carobbio, A; Ghirardi, A; Tognoni, G | |
| Telomere shortening in Ph-negative chronic myeloproliferative neoplasms: a biological marker of polycythemia vera and myelofibrosis, regardless of hydroxycarbamide therapy | 1-gen-2013 | Ruella, M; Salmoiraghi, S; Risso, A; Carobbio, A; Buttiglieri, S; Spatola, T; Sivera, P; Ricca, I; Barbui, T; Tarella, C; Rambaldi, A | |
| Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome | 1-gen-2012 | Barbui, T; Thiele, J; Passamonti, F; Rumi, E; Boveri, E; Randi, Ml; Bertozzi, I; Marino, F; Vannucchi, Am; Pieri, L; Rotunno, G; Gisslinger, H; Gisslinger, B; Mullauer, L; Finazzi, G; Carobbio, A; Gianatti, A; Ruggeri, M; Nichele, I; D'Amore, E; Rambaldi, A; Tefferi, A | |
| Clinical outcomes under hydroxyurea treatment in polycythemia vera: a systematic review and meta-analysis | 1-gen-2019 | Ferrari, A; Carobbio, A; Masciulli, A; Ghirardi, A; Finazzi, G; De Stefano, V; Vannucchi, Am; Barbui, T | |
| Ruxolitinib for the prevention of thrombosis in polycythemia vera: a systematic review and meta-analysis | 1-gen-2020 | Masciulli, A; Ferrari, A; Carobbio, A; Ghirardi, A; Barbui, T | |
| Leukocytosis and risk stratification assessment in essential thrombocythemia | 1-gen-2008 | Carobbio, A; Antonioli, E; Guglielmelli, P; Vannucchi, Am; Delaini, F; Guerini, V; Finazzi, G; Rambaldi, A; Barbui, T | |
| Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms | 1-gen-2018 | De Stefano, V; Carobbio, A; Di Lazzaro, V; Guglielmelli, P; Iurlo, A; Finazzi, Mc; Rumi, E; Cervantes, F; Elli, Em; Randi, Ml; Griesshammer, M; Palandri, F; Bonifacio, M; Hernandez-Boluda, Jc; Cacciola, R; Miroslava, P; Carli, G; Beggiato, E; Ellis, Mh; Musolino, C; Gaidano, G; Rapezzi, D; Tieghi, A; Lunghi, F; Loscocco, Gg; Cattaneo, D; Cortelezzi, A; Betti, S; Rossi, E; Finazzi, G; Censori, B; Cazzola, M; Bellini, M; Arellano-Rodrigo, E; Bertozzi, I; Sadjadian, P; Vianelli, N; Scaffidi, L; Gomez, M; Cacciola, E; Vannucchi, Am; Barbui, T | |
| A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms | 1-gen-2010 | Rambaldi, A; Dellacasa, Cm; Finazzi, G; Carobbio, A; Ferrari, Ml; Guglielmelli, P; Gattoni, E; Salmoiraghi, S; Finazzi, Mc; Di Tollo, S; D'Urzo, C; Vannucchi, Am; Barosi, G; Barbui, T | |
| Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia | 1-gen-2008 | Carobbio, A; Finazzi, G; Antonioli, E; Guglielmelli, P; Vannucchi, Am; Delaini, F; Guerini, V; Ruggeri, M; Rodeghiero, F; Rambaldi, A; Barbui, T | |
| The rate of transformation from JAK2-mutated ET to PV is influenced by an accurate WHO-defined clinico-morphological diagnosis | 1-gen-2015 | Barbui, T; Thiele, J; Carobbio, A; Vannucchi, Am; Tefferi, A | |
| Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis) | 1-gen-2012 | Barbui, T; Finazzi, G; Carobbio, A; Thiele, J; Passamonti, F; Rumi, E; Ruggeri, M; Rodeghiero, F; Randi, Ml; Bertozzi, I; Gisslinger, H; Buxhofer-Ausch, V; De Stefano, V; Betti, S; Rambaldi, A; Vannucchi, Am; Tefferi, A | |
| Innovative haematological parameters for early diagnosis of sepsis in adult patients admitted in intensive care unit | 1-gen-2018 | Buoro, S; Manenti, B; Seghezzi, M; Dominoni, P; Barbui, T; Ghirardi, A; Carobbio, A; Marchesi, G; Riva, I; Nasi, A; Ottomano, C; Lippi, G | |
| High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists | 1-gen-2016 | De Stefano, V; Ruggeri, M; Cervantes, F; Alvarez-Larran, A; Iurlo, A; Randi, Ml; Elli, E; Finazzi, Mc; Finazzi, G; Zetterberg, E; Vianelli, N; Gaidano, G; Rossi, E; Betti, S; Nichele, I; Cattaneo, D; Palova, M; Ellis, Mh; Cacciola, R; Tieghi, A; Hernandez-Boluda, Jc; Pungolino, E; Specchia, G; Rapezzi, D; Forcina, A; Musolino, C; Carobbio, A; Griesshammer, M; Sant'Antonio, E; Vannucchi, Am; Barbui, T | |
| Incidence of solid tumors in polycythemia vera treated with phlebotomy with or without hydroxyurea: ECLAP follow-up data | 1-gen-2018 | Ghirardi, A; Carobbio, A; Masciulli, A; Barbui, T | |
| Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study | 1-gen-2013 | Tefferi, A; Rumi, E; Finazzi, G; Gisslinger, H; Vannucchi, Am; Rodeghiero, F; Randi, Ml; Vaidya, R; Cazzola, M; Rambaldi, A; Gisslinger, B; Pieri, L; Ruggeri, M; Bertozzi, I; Sulai, Nh; Casetti, I; Carobbio, A; Jeryczynski, G; Larson, Dr; Mullauer, L; Pardanani, A; Thiele, J; Passamonti, F; Barbui, T | |
| The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600 | 1-gen-2015 | Massi, D; Brusa, D; Merelli, B; Falcone, C; Xue, G; Carobbio, A; Nassini, R; Baroni, G; Tamborini, E; Cattaneo, L; Audrito, V; Deaglio, S; Mandala, M | |
| Splanchnic Vein Thromboses associated with Myeloproliferative Neoplasms: an international, retrospective study on 518 cases | 1-gen-2020 | Sant'Antonio, E; Guglielmelli, P; Pieri, L; Primignani, M; Randi, Ml; Santarossa, C; Rumi, E; Cervantes, F; Delaini, F; Carobbio, A; Betti, S; Rossi, E; Lavi, N; Harrison, Cn; Curto-Garcia, N; Gisslinger, H; Gisslinger, B; Specchia, G; Ricco, A; Vianelli, N; Polverelli, N; Koren-Michowitz, M; Ruggeri, M; Girodon, F; Ellis, M; Iurlo, A; Mannelli, F; Mannelli, L; Sordi, B; Loscocco, Gg; Cazzola, M; De Stefano, V; Barbui, T; Tefferi, A; Vannucchi, Am | |
| Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor? | 1-gen-2009 | Barbui, T; Carobbio, A; Rambaldi, A; Finazzi, G | |
| Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3 | 1-gen-2011 | Barbui, T; Carobbio, A; Finazzi, G; Vannucchi, Am; Barosi, G; Antonioli, E; Guglielmelli, P; Pancrazzi, A; Salmoiraghi, S; Zilio, P; Ottomano, C; Marchioli, R; Cuccovillo, I; Bottazzi, B; Mantovani, A; Rambaldi, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- Contributo su RIVISTA69851
- Atti di CONVEGNO1
- Contributo su VOLUME1
Data di pubblicazione
- 2020 - 202720192
- 2010 - 201923511
- 2000 - 200914315
- 1990 - 19998032
- 1980 - 19893149
- 1970 - 1979640
- 1966 - 196911
Editore
- Elsevier BV:PO Box 211, 1000 AE A...334
- American Institute of Physics:2 H...226
- Elsevier Science Limited:Oxford F...189
- Giuffre Editore Spa:via Busto Ars...101
- Societa Editrice il Mulino Spa:St...73
- Springer Verlag Germany:Tiergarte...71
- IEEE / Institute of Electrical an...70
- Academic Press Incorporated:6277 ...67
- American Chemical Society:1155 Si...63
- Edizioni Minerva Medica:Corso Bra...59
Rivista
- JOURNAL OF HIGH ENERGY PHYSICS404
- EFSA JOURNAL380
- PLOS ONE315
- PHYSICAL REVIEW LETTERS309
- PHYSICAL REVIEW. B, CONDENSED MAT...294
- SCIENTIFIC REPORTS290
Serie
- EUROPEAN DISTANCE AND E-LEARNING ...1
Keyword
- Humans4564
- Female2681
- Male2251
- Middle Aged1673
- Adult1526
- Aged1328
- Italy767
- Treatment Outcome649
- COVID-19587
- 80 and over506
Lingua
- eng58327
- ita10772
- fre334
- spa299
- ger189
- por61
- rus24
- und23
- chi15
- pol6
Accesso al fulltext
- no fulltext29929
- open19773
- reserved18695
- partially open1440
- embargoed15
- mixed1
